PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro |
Hong, Zhang
(The Nurse Department of Organ Transplantation, Xiangya Hospital, Central South University)
Feng, Zhang (Xiangya School of Medicine, Central South University) Sai, Zhang (Institute of Medical Sciences, Xiangya Hospital, Central South University) Tao, Su (Institute of Medical Sciences, Xiangya Hospital, Central South University) |
1 | Xu, Y., Zhao, F., Wang, Z., Song, Y., Luo, Y., Zhang, X., Jiang, L., Sun, Z., Miao, Z. and Xu, H. (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31, 1398-1407. DOI |
2 | Liu, M., Lang, N., Qiu, M., Xu, F., Li, Q., Tang, Q., Chen, J., Chen, X., Zhang, S., Liu, Z., Zhou, J., Zhu, Y., Deng, Y., Zheng, Y. and Bi, F. (2011) miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int. J. Cancer. 128, 1269-1279. DOI ScienceOn |
3 | Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S. and Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136. DOI ScienceOn |
4 | Weber, D. G., Johnen, G., Bryk, O., Jockel, K. H. and Bruning, T. (2012) Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study. PLoS One 7, e30221. DOI |
5 | Niquet, J. and Wasterlain, C. G. (2004) Bim, Bad, and Bax: a deadly combination in epileptic seizures. J. Clin. Invest. 113, 960-962. DOI ScienceOn |
6 | Danial, N. N. and Korsmeyer, S. J. (2004) Cell death: critical control points. Cell 116, 205-219. DOI ScienceOn |
7 | Shapiro, G. I. (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 24, 1770-1783. DOI ScienceOn |
8 | Xu, Y. (2008) Induction of genetic instability by gain-offunction p53 cancer mutants. Oncogene 27, 3501-3507. DOI ScienceOn |
9 | Vousden, K. H. and Lane, D. P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283. DOI ScienceOn |
10 | Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 DOI ScienceOn |
11 | Yu, D., Zhou, H., Xun, Q., Xu, X., Ling, J. and Hu, Y. (2012) microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol. Lett. 3, 1221-1226. DOI |
12 | Annibali, D., Gioia, U., Savino, M., Laneve, P., Caffarelli, E. and Nasi, S. (2012) A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2. PLoS One 7, e40269. DOI |
13 | Sato, F., Wu, Y., Bhawal, U. K., Liu, Y., Imaizumi, T., Morohashi, S., Kato, Y. and Kijima, H. (2011) PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur. J. Cancer 47, 1747-1758. DOI ScienceOn |
14 | Chen, H. Y., Lin, Y. M., Chung, H. C., Lang, Y. D., Lin, C. J., Huang, J., Wang, W. C., Lin, F. M., Chen, Z., Huang, H. D., Shyy, J. Y., Liang, J. T. and Chen, R. H. (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 72, 3631-3641. DOI ScienceOn |
15 | Sahar, S. and Sassone-Corsi, P. (2009) Metabolism and cancer: the circadian clock connection. Nat. Rev. Cancer 9, 886-896. DOI ScienceOn |
16 | Zhu, Y., Stevens, R. G., Hoffman, A. E., Fitzgerald, L. M., Kwon, E. M., Ostrander, E. A., Davis, S., Zheng, T. and Stanford, J. L. (2009) Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 69, 9315-9322. DOI ScienceOn |
17 | Mazzoccoli, G., Panza, A., Valvano, M. R., Palumbo, O., Carella, M., Pazienza, V., Biscaglia, G., Tavano, F., Di Sebastiano, P., Andriulli, A. and Piepoli, A. (2011) Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol. Int. 28, 841-851. DOI ScienceOn |
18 | Matsuo, T., Yamaguchi, S., Mitsui, S., Emi, A., Shimoda, F. and Okamura, H. (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255-259. DOI ScienceOn |
19 | Gery, S. and Koeffler, H. P. (2007) The role of circadian regulation in cancer. Cold. Spring. Harb. Symp. Quant. Biol. 72, 459-464. DOI ScienceOn |
20 | Buhr, E. D. and Takahashi, J. S. (2013) Molecular components of the Mammalian circadian clock. Handb. Exp. Pharmacol. 217, 3-27. DOI |
21 | Wang, X., Yan, D., Teng, M., Fan, J., Zhou, C., Li, D., Qiu, G., Sun, X., Li, T., Xing, T., Tang, H., Peng, X. and Peng, Z. (2012) Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann. Surg. Oncol. 19, 3081-3088. DOI ScienceOn |
22 | Gaziel-Sovran, A., Segura, M. F., Di Micco, R., Collins, M. K., Hanniford, D., Vega-Saenz, D. M. E., Rakus, J. F., Dankert, J. F., Shang, S., Kerbel, R. S., Bhardwaj, N., Shao, Y., Darvishian, F., Zavadil, J., Erlebacher, A., Mahal, L. K., Osman, I. and Hernando, E. (2011) miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 20, 104-118. DOI ScienceOn |